Skip to content
OpenCapital
Get started

Organon OGN EBIT

EBIT at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
$141.77M+41.3%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$62.5M+60.3%
Pfizer logo
PfizerPFE
——
Amgen logo
AmgenAMGN
——
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
——
AbbVie logo
AbbVieABBV
——

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%—
Debt / equity9.5×-7.0×
Current ratio2×+0.3×

Where this comes from

Calculated from Organon’s reported figures.

$213.0Mincome before tax+$111.0Minterest expense=$324M

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's EBIT?
Organon (OGN) reported EBIT of $324M in Q1 2026.
How has Organon's EBIT changed year-over-year?
Organon's EBIT increased by 44.0% year-over-year, from $225M to $324M.
What is the long-term trend for Organon's EBIT?
Over 3 years (2021 to 2024), Organon's EBIT has grown at a -9.4% compound annual growth rate (CAGR), from $1.79B to $1.33B.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.